Sharekhan By BNP Paribas: 2 top stock picks from Foram Parekh for near term
“In North America, Revlimid is the key contributor and again, speciality drugs for Zydus Lifesciences that will keep on increasing EBITDA margins towards 29-30% and also in the valuation-wise Zydus …
